Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-000705

Chief Executive Officer bought 166,666 shares at $0.30 ($50,000)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-01 Purchase : show line 1 in the form +166,666 $0.30 $50,000 215,676 D
Open-market purchases · 166,666 sh · avg $0.30 · $50,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-01 Grant or award : show line 2 in the form Series A Warrant to purchase common stock +166,666 226,867 D
2024-02-01 Grant or award : show line 3 in the form Series B Warrant to purchase common stock +166,666 393,533 D
Loading xslF345X05/ownership.xml…